Some posters view pessimism as a contrarian indicator, while others are taking a muted approach to investing in emerging markets .
New product pipeline buzz and management’s bullishness on holiday revenue growth overshadow modestly disappointing third-quarter revenue, says Morningstar’s Brian Colello.
We chatted with GMO's Ben Inker about where the markets are offering the best rewards and the biggest risks.
©2014 Morningstar Advisor. All right reserved.